TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9741655

Group type: EXPERIMENTAL
Intervention: Hyoscine butylbromide (HBB) 10 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Atropine sulphate 0.4 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 10
Study: 8059044

Group type: EXPERIMENTAL
Intervention: Fentanyl 1 microgram/kg/h and bupivacaine 0.125% with boluses of 12.5 micrograms fentanyl and bupivacaine at 0.125%
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fentanyl (control group)
Number of subjects: 20
Study: 3058102

Group type: EXPERIMENTAL
Intervention: Tono-Pen
Number of subjects: 115

Group type: COMPARATOR
Intervention: MacKay-Marg tonometer
Number of subjects: 115
Study: 30864532

Group type: EXPERIMENTAL
Intervention: Home treatment alternative to hospital care (experimental group)
Number of subjects: 707

Group type: COMPARATOR
Intervention: Conventional service model without home treatment (control group)
Number of subjects: 707
Study: 31486730

Group type: EXPERIMENTAL
Intervention: Surgeon-PC team co-management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgeon-alone management
Number of subjects: 0
Study: 28632865

Group type: EXPERIMENTAL
Intervention: Cetuximab combined with mFOLFOX6 or FOLFIRI chemotherapy
Number of subjects: 1137

Group type: COMPARATOR
Intervention: Bevacizumab combined with mFOLFOX6 or FOLFIRI chemotherapy
Number of subjects: 1137

Group type: EXPERIMENTAL
Intervention: Cetuximab
Number of subjects: 1137

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 1137
Study: 26156277

Group type: EXPERIMENTAL
Intervention: CCLAD
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 20% benzocaine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Cartridge syringe
Number of subjects: 120

Group type: COMPARATOR
Intervention: Pressure with cotton applicator
Number of subjects: 120

Group type: COMPARATOR
Intervention: No topical application
Number of subjects: 120
Study: 23842741

Group type: EXPERIMENTAL
Intervention: Rhinoplasty with defatting tip and supratip skin
Number of subjects: 55

Group type: COMPARATOR
Intervention: Rhinoplasty without defatting tip and supratip skin (control group)
Number of subjects: 55
Study: 21132546

Group type: EXPERIMENTAL
Intervention: Caffeine supplementation (CAF)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Caffeine supplementation (CAF) and Exercise
Number of subjects: 6
Study: 19110505

Group type: EXPERIMENTAL
Intervention: Pitavastatin
Number of subjects: 160

Group type: COMPARATOR
Intervention: Pravastatin
Number of subjects: 160
Study: 17031654

Group type: EXPERIMENTAL
Intervention: Simultaneous ureteric catheter insertion
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sequential ureteric catheter insertion
Number of subjects: 24
Study: 15173489

Group type: EXPERIMENTAL
Intervention: Parent reports of ADHD symptoms
Number of subjects: 1445

Group type: COMPARATOR
Intervention: Teacher reports of ADHD symptoms
Number of subjects: 1445
Study: 15569286

Group type: EXPERIMENTAL
Intervention: Early Intervention Programme (EIP)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control (routine medical nursing care)
Number of subjects: 23
Study: 10077720

Group type: EXPERIMENTAL
Intervention: Bioresonance therapy (10 sessions)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Speech therapy (control group)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Speech therapy (after bioresonance therapy)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Bioresonance therapy (after speech therapy)
Number of subjects: 14
Study: 7740939

Group type: EXPERIMENTAL
Intervention: Traditional medial bone‐patellar tendon graft
Number of subjects: 40

Group type: COMPARATOR
Intervention: Half‐thickness patellar tendon graft augmented with the Kennedy Ligament Augmentation Device (LAD)
Number of subjects: 40
Study: 2184133

Group type: EXPERIMENTAL
Intervention: Disulfiram 100 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Disulfiram 400 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 7288210

Group type: EXPERIMENTAL
Intervention: Group 1 (high DNAP levels)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Group 2 (low DNAP levels)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Group 1 and Group 2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Viral replication
Number of subjects: 20
Study: 30394337

Group type: EXPERIMENTAL
Intervention: Nurse-led complex package of care for gout
Number of subjects: 30
Study: 30306603

Group type: EXPERIMENTAL
Intervention: Low-FODMAP diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Typical-Australian diet
Number of subjects: 20
Study: 26572280

Group type: EXPERIMENTAL
Intervention: Active tDCS (1.0 mA anodal stimulation over the left DLPFC with cathodal stimulation over the right supra-orbital area)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 25
Study: 24874344

Group type: EXPERIMENTAL
Intervention: Elective interval appendectomy (IA), median interval 76 days, range 29-230 days
Number of subjects: 69

Group type: COMPARATOR
Intervention: Emergency appendectomy
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy
Number of subjects: 69
Study: 21703848

Group type: EXPERIMENTAL
Intervention: Preoperative treatment according to the localised-disease protocol
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Preoperative treatment according to the metastatic-disease protocol
Number of subjects: 103

Group type: COMPARATOR
Intervention: True localised disease
Number of subjects: 103

Group type: COMPARATOR
Intervention: Metastatic disease
Number of subjects: 103
Study: 19829096

Group type: EXPERIMENTAL
Intervention: Vitamin E (400 international units daily for 12 weeks)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group not mentioned
Number of subjects: 19
Study: 19425483

Group type: EXPERIMENTAL
Intervention: Developmental dyslexia (W, S, M)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control group (children without ophthalmological pathological state)
Number of subjects: 176
Study: 16249540

Group type: EXPERIMENTAL
Intervention: Ruboxistaurin 32 mg/day for 1 year
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 11852155

Group type: EXPERIMENTAL
Intervention: Mouth shape presented in isolation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mouth shape embedded in original photos
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mouth shape in exchanged facial context
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conflicting mouth shape and facial context
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attended stimuli in correct facial context
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isolated mouth stimuli
Number of subjects: 0
Study: 10102956

Group type: EXPERIMENTAL
Intervention: 20 mg curcumin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 8703664

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg daily for 15 days
Number of subjects: 13
Study: 29243058

Group type: EXPERIMENTAL
Intervention: 8 mg ondansetron IV (group O)
Number of subjects: 108

Group type: COMPARATOR
Intervention: 4 ml saline (group S)
Number of subjects: 108
Study: 28778993

Group type: EXPERIMENTAL
Intervention: Protein, carbohydrate, and fat mixture (meal replacement)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Amino acid (AA) beverage
Number of subjects: 8
Study: 25746712

Group type: EXPERIMENTAL
Intervention: ON-Q pain relief system
Number of subjects: 0
Study: 23280270

Group type: EXPERIMENTAL
Intervention: Out-and-About program
Number of subjects: 300

Group type: COMPARATOR
Intervention: Written guidelines only
Number of subjects: 300
Study: 21237167

Group type: EXPERIMENTAL
Intervention: Novel follow-up system (letters to primary care provider, 2 letters to patient, telephone call)
Number of subjects: 830

Group type: COMPARATOR
Intervention: Standard of care (no follow-up system)
Number of subjects: 830

Group type: EXPERIMENTAL
Intervention: Novel follow-up system
Number of subjects: 830
Study: 19488587

Group type: EXPERIMENTAL
Intervention: One-stage continuous curvilinear capsulorhexis (1-CCC)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Two-stage continuous curvilinear capsulorhexis (2-CCC)
Number of subjects: 24
Study: 16500499

Group type: EXPERIMENTAL
Intervention: Endothelium‐dependent flow‐mediated dilation (FMD)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nonendothelium‐dependent dilation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Aortic strain
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Aortic distensibility
Number of subjects: 30
Study: 15617613

Group type: EXPERIMENTAL
Intervention: Childhood vegetable intake
Number of subjects: 1227

Group type: EXPERIMENTAL
Intervention: Childhood fruit intake
Number of subjects: 1227
Study: 10791526

Group type: EXPERIMENTAL
Intervention: New treatment schedule (10 daily injections of 2.2 mg/kg)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Standard treatment schedule (26-day regimen of melarsoprol with doses increasing from 1.2 to 3.6 mg/kg)
Number of subjects: 500
Study: 9289940

Group type: EXPERIMENTAL
Intervention: Tensiomin (50 mg)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Tensiomin (100 mg)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Capoten (50 mg)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Capoten (100 mg)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Lopirin (50 mg)
Number of subjects: 49
Study: 8240197

Group type: EXPERIMENTAL
Intervention: Pressurization to 200 mBar for 3 h
Number of subjects: 51

Group type: COMPARATOR
Intervention: Rest (Control)
Number of subjects: 51
Study: 3602016

Group type: EXPERIMENTAL
Intervention: Twice daily regimen of combined inhalation of salbutamol and beclomethasone dipropionate from a single inhaler
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 4-times daily regimen of combined inhalation of salbutamol and beclomethasone dipropionate from a single inhaler
Number of subjects: 20

Group type: COMPARATOR
Intervention: Separate inhalers for salbutamol and beclomethasone dipropionate
Number of subjects: 20
Study: 30514741

Group type: EXPERIMENTAL
Intervention: Hill's Prescription Diet k/d Feline with chicken, dry
Number of subjects: 28

Group type: COMPARATOR
Intervention: Royal Canin Renal Support A Feline, dry
Number of subjects: 28
Study: 27645692

Group type: EXPERIMENTAL
Intervention: Metabolic tumor volume (MTV) pre-treatment >32 mL
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Higher tMTV-pre (per 10-mL increase)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Radiotherapy dose (≤60 Gy vs. 61-69 Gy or ≥70 Gy) in patients with tMTV-pre >32 mL
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Radiotherapy dose in patients with tMTV-pre ≤32 mL
Number of subjects: 230
Study: 25190222

Group type: EXPERIMENTAL
Intervention: POST intervention (4 sessions pre-release and 2 sessions post-release focusing on HIV prevention and access to care)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 0
Study: 23417103

Group type: EXPERIMENTAL
Intervention: Partially paralyzed hands (PPH)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Completely paralyzed hands (CPH)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All stroke patients
Number of subjects: 24
Study: 21654533

Group type: EXPERIMENTAL
Intervention: PAP stimulus (1 set of 3 repetitions at 87% 1RM)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Individualized race specific warm-up
Number of subjects: 9
Study: 18063650

Group type: EXPERIMENTAL
Intervention: Personal feedback (P feedback)
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Personal-normative feedback (PN feedback)
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Personal-normative-action feedback (PNA feedback)
Number of subjects: 588

Group type: COMPARATOR
Intervention: Generic information
Number of subjects: 588
Study: 16567272

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 37

Group type: COMPARATOR
Intervention: Low-fat diet (control)
Number of subjects: 37
Study: 14501447

Group type: EXPERIMENTAL
Intervention: Oral corticosteroids (Prednisone 60mg and taper)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 0
Study: 10892822

Group type: EXPERIMENTAL
Intervention: Telecommunications approach with spiritual and hypertension-related messages via programmed telephone calls
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control group receiving spiritual messages only
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Both groups (experimental and control)
Number of subjects: 83
Study: 8616024

Group type: EXPERIMENTAL
Intervention: Melphalan/prednisone
Number of subjects: 581

Group type: COMPARATOR
Intervention: Melphalan/prednisone + interferon alpha-2b
Number of subjects: 581
Study: 1594378

Group type: EXPERIMENTAL
Intervention: Standardized verbal instructions given by housestaff and students trained in their use (verbal group)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Standardized verbal instructions plus a type-written copy of the information to take home (verbal + written group)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Instruction by individual housestaff and medical students after consultation with an attending physician (control group)
Number of subjects: 197
Study: 3876532

Group type: EXPERIMENTAL
Intervention: Vitrectomy (RAN-S)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control (RAN-C)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Long-term observation (LTO)
Number of subjects: 136
Study: 28503770

Group type: EXPERIMENTAL
Intervention: Intravenous levetiracetam (LEVIV) 20 mg/kg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intranasal crushed immediate release levetiracetam (LEVCIR) 30 mg/kg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intranasal crushed extended release levetiracetam (LEVCER) 30 mg/kg
Number of subjects: 9
Study: 28231815

Group type: EXPERIMENTAL
Intervention: Telerehabilitation programme (videoconferences)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional physiotherapy intervention
Number of subjects: 0
Study: 26246692

Group type: EXPERIMENTAL
Intervention: Standardized fitness training (20 sessions over 8-12 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 40
Study: 22682875

Group type: EXPERIMENTAL
Intervention: 300 mg CoQ10 + 300 IU vitamin E
Number of subjects: 236

Group type: COMPARATOR
Intervention: Placebo + 300 IU vitamin E
Number of subjects: 236
Study: 21347907

Group type: EXPERIMENTAL
Intervention: Standard behavioral group therapy
Number of subjects: 39

Group type: COMPARATOR
Intervention: Smoker control group without treatment
Number of subjects: 39

Group type: COMPARATOR
Intervention: Non-smoker control group
Number of subjects: 39
Study: 17311241

Group type: EXPERIMENTAL
Intervention: New treatment for stress urinary incontinence
Number of subjects: 0
Study: 16566612

Group type: EXPERIMENTAL
Intervention: Baseline assessments including sociodemographic characteristics and measures of depressive symptom severity
Number of subjects: 1397

Group type: EXPERIMENTAL
Intervention: Clinical features and sociodemographic characteristics
Number of subjects: 1397
Study: 14731163

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) + dideoxycytidine (ddC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) + didanosine (ddI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Zidovudine (ZDV)
Number of subjects: 0
Study: 11180310

Group type: COMPARATOR
Intervention: Standard 'Western' ANC model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 'New' ANC model consisting of tests, clinical procedures and follow‐up actions scientifically demonstrated to be effective in improving maternal and newborn outcomes
Number of subjects: 0
Study: 9392500

Group type: EXPERIMENTAL
Intervention: Linoleic acid-enriched, low-cholesterol diet
Number of subjects: 44
Study: 7941195

Group type: EXPERIMENTAL
Intervention: 1 mg SIN-1
Number of subjects: 113

Group type: COMPARATOR
Intervention: P/P (papaverine 15 mg/mL and phentolamine 0.5 mg/mL)
Number of subjects: 113

Group type: COMPARATOR
Intervention: P/P
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: SIN-1
Number of subjects: 113
Study: 3048870

Group type: EXPERIMENTAL
Intervention: Lippes Loop
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Multiload-250 and Multiload-375
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: TCu 200 and Copper-7
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: ProgestasertR
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Serum ferritin
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Haemoglobin (HGB) concentrations
Number of subjects: 395
Study: 31790692

Group type: EXPERIMENTAL
Intervention: IPE supplementation with moderate intensity exercise training (EX/IPE group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo supplementation with moderate intensity exercise training (EX/Placebo group)
Number of subjects: 20
Study: 30454001

Group type: EXPERIMENTAL
Intervention: Preoperative percutaneous catheter drainage (PCD)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no PCD)
Number of subjects: 72
Study: 26494875

Group type: EXPERIMENTAL
Intervention: Healthy Activity Program (HAP) delivered over 6-8 sessions, focusing on behavioral activation, problem-solving, and social network activation
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 55
Study: 25005339

Group type: EXPERIMENTAL
Intervention: Procalcitonin guidance (n=50)
Number of subjects: 110

Group type: COMPARATOR
Intervention: State-of-the-art guidelines (controls, n=60)
Number of subjects: 110
Study: 22917813

Group type: EXPERIMENTAL
Intervention: Enzastaurin (1125 mg on Day 1 followed by 500 mg daily)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Enzastaurin
Number of subjects: 107
Study: 20516686

Group type: EXPERIMENTAL
Intervention: 250 ppm F (amine F/NaF) mouthrinse
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo mouthrinse
Number of subjects: 16
Study: 18338098

Group type: EXPERIMENTAL
Intervention: 14-mm thick horseshoe-shaped protector
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 16-mm thick continuous protector
Number of subjects: 15
Study: 16191912

Group type: EXPERIMENTAL
Intervention: Self-etch adhesive (Adper Prompt)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Etch & rinse adhesive (Single-Bond)
Number of subjects: 25
Study: 12957426

Group type: EXPERIMENTAL
Intervention: Short-term vitamin C administration (3 g intravenous infusion)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Long-term vitamin C treatment (2 g daily for 3 months)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Long-term vitamin C treatment (2 g daily for 2 years)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Short-term vitamin C infusion (3 g intravenous infusion)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Short-term vitamin C treatment (3 g intravenous infusion)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (saline infusion)
Number of subjects: 50
Study: 10817181

Group type: EXPERIMENTAL
Intervention: Endoscopic therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observational studies
Number of subjects: 0
Study: 8664039

Group type: EXPERIMENTAL
Intervention: FNA-PCR (polymerase chain reaction)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Conventional cytopathology
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: FNA-PCR
Number of subjects: 27

Group type: COMPARATOR
Intervention: Controls (disease-free patients)
Number of subjects: 27
Study: 1522084

Group type: EXPERIMENTAL
Intervention: Miconazole varnish (single-dose application)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Miconazole gel (applied three times/day for 15 days)
Number of subjects: 50
Study: 6149940

Group type: EXPERIMENTAL
Intervention: 0.25 mg triazolam
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.5 mg triazolam
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (Group A)
Number of subjects: 24
Study: 31575375

Group type: EXPERIMENTAL
Intervention: Low energy diet (LED) + Aerobic Interval Training (AIT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Aerobic Interval Training (AIT)
Number of subjects: 70
Study: 30106266

Group type: EXPERIMENTAL
Intervention: Ifenprodil (60 mg per day for 3 months)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control (600 mg ascorbic acid and calcium pantothenate per day for 3 months)
Number of subjects: 68
Study: 27001608

Group type: EXPERIMENTAL
Intervention: Complex intervention including practice based workshops, posters, computer prompts, and testing feedback.
Number of subjects: 29
Study: 25253123

Group type: EXPERIMENTAL
Intervention: Severe airway obstruction (FEV1/FVC ratio <0.7)
Number of subjects: 3104

Group type: EXPERIMENTAL
Intervention: Prior use of inhaled steroids
Number of subjects: 3104

Group type: COMPARATOR
Intervention: Antibiotic therapy
Number of subjects: 3104
Study: 22934586

Group type: EXPERIMENTAL
Intervention: Near-peer shadowing program for first-year medical students
Number of subjects: 83
Study: 20467288

Group type: EXPERIMENTAL
Intervention: Raltegravir-based therapy
Number of subjects: 273

Group type: COMPARATOR
Intervention: Ritonavir-boosted protease inhibitor-based therapy
Number of subjects: 273
Study: 18638004

Group type: EXPERIMENTAL
Intervention: Mirodenafil 50 mg
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Mirodenafil 100 mg
Number of subjects: 223

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study: 15838185

Group type: EXPERIMENTAL
Intervention: Paroxetine-Alprazolam Placebo (PAP)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Paroxetine Placebo-Alprazolam (PPA)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Paroxetine-Alprazolam (PA)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Paroxetine Placebo-Alprazolam Placebo (PLA)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Paroxetine-Alprazolam (PAP)
Number of subjects: 22
Study: 12679664

Group type: EXPERIMENTAL
Intervention: rhBMP-2 on an absorbable collagen sponge
Number of subjects: 679

Group type: COMPARATOR
Intervention: autograft from the iliac crest
Number of subjects: 679
Study: 10486418

Group type: EXPERIMENTAL
Intervention: Amiodarone (300 mg intravenous)
Number of subjects: 504

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 504
Study: 8666569

Group type: EXPERIMENTAL
Intervention: Buspirone (15 to 45 mg/day)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162